Remarkable results: DAAs decrease hep C deaths

Ideally, double the number of GPs would be writing scripts

Hepatitis C deaths have declined by 20% in the two years since direct-acting antivirals were added to the PBS, infectious diseases physicians say.

Professor Greg Dore

Presenting study findings based on more than 100,000 patients with a hepatitis C diagnosis in NSW, Professor Greg Dore, from the Kirby Institute, says the decline in deaths among patients with liver disease is remarkable and testament to the high uptake of the drugs.

Speaking from the Australasian Viral Hepatitis Conference in Adelaide on Monday, he told Australian Doctor the number of patients initiated on